This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Recurrent Pterygium
and you are
between 18 and 80
years old
The phase for this study is not defined.
Show me locations

The purpose

To compare the outcomes of limbal conjunctival autograft (LCAG) versus amniotic membrane graft (AMG) when combined with intraoperative 0.02% mitomycin C (MMC) after pterygium removal in patients with recurrent pterygium.

Provided treatments

  • Procedure: MMC
  • Procedure: LCAG
  • Procedure: AMG

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01319721. The sponsor of the trial is Shiyou Zhou and it is looking for 96 volunteers for the current phase.
Official trial title:
Limbal Conjunctival Autograft Versus Amniotic Membrane Graft When Combined With Mitomycin C for Recurrent Pterygium: A Randomized Trial